Activating GPR40, a receptor on thymic epithelial cells, substantially delays thymic involution in aged mice, restoring T cell populations and reducing cellular senescence. This receptor-specific approach addresses a fundamental mechanism of immune aging without apparent systemic toxicity.
Key Points
- GPR40 activation increased thymus weight 50% over control in aged mice
- Treatment reduced drug-induced senescence in thymic cells from 85% to 20%
- Multiple T cell subsets expanded, including naïve cells linked to healthspan
Longevity Analysis
Thymic involution is a hallmark of immune aging, directly reducing the body's capacity to generate new T cells and respond to infection or vaccination. This work identifies a specific molecular lever—GPR40—that can reverse structural and functional decline in the thymic epithelium, the tissue responsible for T cell maturation. The dual mechanism observed here—both restoring epithelial cell function and reducing senescence—suggests a pathway that could translate to therapeutic interventions for age-related immune dysfunction, particularly relevant for post-vaccination responses and infection susceptibility in older populations.
Original published by LifeSpan.io, by Josh Conway.